Incorrect Survival Prediction Ups Aggressive End-of-Life Care

October 25, 2018

(Medscape) – An inability to accurately predict how long patients with metastatic lung cancer have left to live increases the likelihood of aggressive, poor-quality end-of-life care of dubious benefit, new research suggests. “Previous studies have shown that increased and intensive cancer treatment at the end of life is associated with decreased quality of life for patients, increased costs, and [that such care] often contradicts the wishes of patients and their families,” said Katherine Sborov, BA, of the Stanford Cancer Institute in California.